After gene differential analysis, we observed that, in tumor samples, CLDN10-AS1 was upregulated, while SFTA1P, SRGAP3-AS2, and ADAMTS9-AS2 were downregulated (Figure 9). This evidence concerns the gene ADAMTS9 and neoplasm.